GNRH1 and ovarian hyperstimulation syndrome: In addition, small sample studies performed by Hosseini et al (19) and Bonilla-Musoles et al (6) revealed that the symptoms of OHSS and the degree of severity significantly decreased following the administration of a GnRH-ant to severe early-onset OHSS patients during the luteal phase.